METIS TECHBIO-P (07666) has been included in the Hang Seng Composite Index constituent stocks.

METIS TECHBIO-P (07666) announced that, based on the results of the quarterly review of the Hang Seng Index series published by Hang Seng Indexes Company Limited on August 21, 2026, for the period ending June 30, 2026, the company has been selected and will be included as a constituent stock of the Hang Seng Composite Index, effective from September 7, 2026. As a comprehensive benchmark indicator for the Hong Kong market, the Hang Seng Composite Index covers the top 95% of listed companies on the main board of Hong Kong Exchanges and Clearing Limited (HKEX) ranked by cumulative market capitalization. This index serves as a widely applicable benchmark for index funds, mutual funds, and investment performance evaluation. After being included as a constituent stock of the Hang Seng Composite Index, the H shares issued and listed by the company on the HKEX are expected to qualify for trading under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect. These initiatives provide trading and investment channels between investors in Hong Kong and those in mainland China. The Board of Directors believes that inclusion as a constituent stock of the Hang Seng Composite Index reflects the high recognition of the company's investment value and growth prospects by the international capital market. This will help broaden the shareholder base and attract more long-term institutional investors, enhance the trading liquidity of the company's shares, and lay a solid foundation for the company's long-term development, thereby enhancing the company's investment value and reputation in the capital market.